secwatch.observer — SEC 8-K summary
======================================

Issuer:     Z Squared Inc. (ZSQR)
CIK:        0001759186
Form:       8-K
Filed at:   2023-10-13T23:59:59+00:00
Accession:  0001683168-23-007115
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Coeptis Therapeutics issues 3M shares to two investors for $3M; $500k cash, $2.5M notes due 2024
--------------------------------------------------------------------------------

- Issued 2.4M shares to Biofin Ventures for $2.4M ($400k cash + $2M promissory note due Aug 2024).
- Issued 600k shares to AG Bio Life Capital I for $600k ($100k cash + $500k note due Aug 2024).
- Notes bear 6% interest (18% on default), payable by Aug 30, 2024; investors may prepay.
- If Biofin or AG sell shares before maturity, proceeds from sales must be contributed to the company.
- Unregistered issuance dilutes existing shareholders by ~3M shares; only $500k received upfront.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759186/000168316823007115/0001683168-23-007115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759186/000168316823007115/coeptis_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-007115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer